SCGB2A2 is a member of the superfamily of secretoglobins, a group of small dimeric secreted and sometimes glycosylated proteins. Expressed mainly in mucosa, secretoglobins seem to be involved in cell signalling, immune response, and chemotaxis, and may also serve as transporters for steroid hormones in humans.[8]
SCGB2A2 expression is highly specific of mammary tissue, and is increasingly used for identification and detection of disseminated breast cancer cells.[9]
^Watson MA, Fleming TP (Jul 1996). "Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer". Cancer Res. 56 (4): 860–5. PMID8631025.
Carter D, Douglass JF, Cornellison CD, Retter MW, Johnson JC, Bennington AA, Fleming TP, Reed SG, Houghton RL, Diamond DL, Vedvick TS (2002). "Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer". Biochemistry. 41 (21): 6714–22. doi:10.1021/bi0159884. PMID12022875.
Izmailova E, Bertley FM, Huang Q, Makori N, Miller CJ, Young RA, Aldovini A (2003). "HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages". Nat. Med. 9 (2): 191–7. doi:10.1038/nm822. PMID12539042. S2CID26145639.
Cerveira N, Torres L, Rocha P, Bizarro S, Pereira D, Abreu J, Henrique R, Teixeira MR, Castedo S (2004). "Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients". Int. J. Cancer. 108 (4): 592–5. doi:10.1002/ijc.11609. PMID14696125. S2CID13567521.
Ouellette RJ, Richard D, Maïcas E (2004). "RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes". Am. J. Clin. Pathol. 121 (5): 637–43. doi:10.1309/MMAC-TXT5-5L8Q-TKC1. PMID15151203. S2CID35965043.
Ferrucci PF, Rabascio C, Mazzetta C, Cocorocchio E, Agazzi A, Vanazzi A, Cinieri S, Peccatori FA, Paolucci M, Bertolini F, Martinelli G (2005). "Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer". Clin. Cancer Res. 10 (18 Pt 1): 6039–46. doi:10.1158/1078-0432.CCR-03-0453. PMID15447988. S2CID28424184.
Roncella S, Ferro P, Bacigalupo B, Pronzato P, Tognoni A, Falco E, Gianquinto D, Ansaldo V, Dessanti P, Fais F, Rosai J, Fedeli F (2005). "Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood". J. Exp. Clin. Cancer Res. 24 (2): 265–71. PMID16110760.
Roncella S, Ferro P, Bacigalupo B, Dessanti P, Giannico A, Gorji N, Moroni M, Tozzini S, Pensa F, Gianquinto D, Fais F, Pronzato P, Fedeli F (2006). "Relationship between human mammaglobin mRNA expression in breast cancer tissue and clinico-pathologic features of the tumors". J. Exp. Clin. Cancer Res. 25 (1): 65–72. PMID16761620.
Ntoulia M, Stathopoulou A, Ignatiadis M, Malamos N, Mavroudis D, Georgoulias V, Lianidou ES (2007). "Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR". Clin. Biochem. 39 (9): 879–87. doi:10.1016/j.clinbiochem.2006.06.009. PMID16925986.
Gimbergues P, Dauplat MM, Cayre A, Durando X, Le Bouedec G, Finat-Duclos F, Portefaix G, Kwiatkowski F, Dauplat J, Penault-Llorca F, Tchirkov A (2007). "Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category". Eur J Surg Oncol. 33 (1): 16–22. doi:10.1016/j.ejso.2006.09.013. PMID17071045.